A. BİLİCİ Et Al. , "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer," 2010 Gastrointestinal Cancers Symposium , United States Of America, 2010
BİLİCİ, A. Et Al. 2010. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer. 2010 Gastrointestinal Cancers Symposium , (United States Of America).
BİLİCİ, A., USTAALİOĞLU, B., GÜMÜŞ, M., ŞEKER, M., ERKOL, B., SÖNMEZ, B., ... YILDIRIM, M. E.(2010). Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer . 2010 Gastrointestinal Cancers Symposium, United States Of America
BİLİCİ, AHMET Et Al. "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer," 2010 Gastrointestinal Cancers Symposium, United States Of America, 2010
BİLİCİ, AHMET Et Al. "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer." 2010 Gastrointestinal Cancers Symposium , United States Of America, 2010
BİLİCİ, A. Et Al. (2010) . "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer." 2010 Gastrointestinal Cancers Symposium , United States Of America.
@conferencepaper{conferencepaper, author={AHMET BİLİCİ Et Al. }, title={Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer}, congress name={2010 Gastrointestinal Cancers Symposium}, city={}, country={United States Of America}, year={2010}}